PureHealth, the largest healthcare group in the Middle East, has agreed to acquire a 60% stake in Hellenic Healthcare Group (HHG) for $2.3bn.

This deal reinforces PureHealth’s global expansion strategy, strengthening its footprint in Europe and advancing its mission to deliver transformative care.

HHG operates 10 hospitals and 16 diagnostic centres across Greece and Cyprus. It serves 1.4 million patients annually through more than 6,700 healthcare professionals. The group offers a wide range of medical specialties, including oncology, cardiology, neurosurgery, and IVF treatments.

CVC Capital Partners, the previous majority owner of HHG, will retain a 35% stake, while 5% will remain with HHG’s founder. PureHealth plans to leverage HHG’s capabilities to enhance operational efficiency and expand its offerings. This would position the group as a leader in the European private healthcare market.

“This acquisition marks a significant milestone in our strategic expansion, strengthening our presence in Europe while diversifying revenues and driving operational synergies,” said Shaista Asif, CEO of PureHealth. Chairman Hamad Al Hammadi added, “This partnership highlights our commitment to global healthcare leadership and innovation.”

The Greek and Cypriot healthcare markets offer substantial growth opportunities, driven by increasing demand for private healthcare services and investment in healthcare infrastructure. HHG’s strong market position makes it a valuable addition to PureHealth’s growing portfolio.

This deal follows PureHealth’s acquisition of Circle Health Group in the UK for $1.2bn and a $500m stake in Ardent Health Services in 2022, further underscoring the group’s focus on international growth and value creation.

The transaction is subject to regulatory approvals and is expected to close upon meeting customary conditions.

Source: PR Newswire

Can’t stop reading? Read more

2025 News

Add Your Short Heading Text Here Balbec Capital closed its latest credit fund, Insolve Global...

read more